Hasil Pencarian  ::  Simpan CSV :: Kembali

"Tujuan: Mengetahui kesintasan hidup, respon pengobatan dan faktor yang mungkin mempengaruhi dalam penanganan karsinoma nasofaring stadium lokal lanjut. Metode: Dilakukan penelitian retrospektif deskriptif analitik terhadap 391 pasien karsinoma nasofaring stadium lokal lanjut yang berobat di Departemen Radioterapi RSCM periode Januari 2007-Desember 2011, dilihat karakteristik pasien maupun tumor. Analisis kesintasan dihitung dengan kurva Kaplan Meier dan respon radiasi dianalisa menggunakan uji korelasi Spearman pada pasien yang memenuhi kriteria inklusi. Hasil: Didapatkan 70.6% pasien adalah laki laki, median usia 45 (9-86) tahun. Sebagian besar stadium IVB (32,7%) dengan tipe histopatologis WHO III paling dominan (82,4%) Kesintasan hidup 3 dan 5 tahun untuk masing-masing stadium IIB, III, IVA, IVB berturut-turut adalah 64,9%, 57,6%, 47,4%, 48,0% dan 64,9%, 43,2%, 34,3%, 26,6%. Sedangkan respon komplit untuk masing-masing stadium IIB, III, IVA, IVB berturut-turut 83,3%, 73,3%, 52,6%, 45,8%. Terdapat korelasi bermakna antara respon radiasi dengan stadium (r=0,242;p=0,038) dan antara respon radiasi dan kesintasan hidup (r=-0,251;p=0,031).

---

Purpose: To show the overall survival rate, radiation response and factors influenced on locally advanced nasopahryngeal cancer.

Method: Retrospective analytic descriptive study of 391 newly diagnosed locally advanced nasopharyngeal cancer patients from January 2007 till December 2011, to show their characteristics. Overall survival rate were analyzed by Kaplan Meier Survival curve and the radiation response correlation with other factors were analyzed by Spearman correlation test.

Result: Most of the subjects are male (70.6%), with median age 45 (9-86) years old. Mainly on stage IVB (32,79%) with the most hystopalogic was type III WHO (82,4%). All of the subjects were analyzed for 3 and 5 years overall survival, resulted for stage IIB, III, IVA, IVB were 64,9%, 57,6%, 47,4%, 48,0% dan 64,9%, 43,2%, 34,3%, 26,6% respectively. Complete respons for stage IIB, III, IVA, IVB were 83,3%, 73,3%, 52,6%, 45,8%, respectively. There were significant correlation between radiation response and cancer stadium (r=0,242;p=0,038) and between radiation response with overall survival rate (r=-0,251;p=0,031)."

"Latar belakan: Kanker serviks merupakan kanker terbanyak kedua dan tingkat kematian terbesar ketiga di Indonesia. Sebagian besar pasien datang dengan stadium lanjut (IIB-IIIB), sehingga terapi pilihan untuk pasien adalah radioterapi atau kemoradiasi. Penelitian sebelumnya membuktikan bahwa terdapat perbedaan respon tumor antara pasien yang dilakukan radiasi di pagi hari dibandingkan sore hari. Terlepas dari hal tersebut, kualitas dan kuantitas tidur dihubungkan dengan peningkatan faktor karsinogenik yang dapat menyebabkan imunosupresi. Penelitian juga menunjukkan bahwa gangguan tidur merupakan faktor prognostik independen dalam memengaruhi overall survival pasien kanker kolorektal. Penelitian ini bertujuan untuk mengetahui hubungan antara kualitas dan kuantitas tidur terhadap respon klinis pada pasien kanker serviks stadium lokal lanjut yang menjalani radioterapi.Metode: Penelitian ini menggunakan desain studi cross-sectional pada pasien kanker serviks stadium IIB – IIIB yang telah menjalani radioterapi di IPTOR RSCM. Data pola dan kebiasaan tidur didapatkan dari wawancara yang telah dilakukan kepada pasien kanker serviks dari penelitian terdahulu oleh Ramli dkk., berupa durasi, kualitas, dan jam mulai tidur malam, serta frekuensi, durasi, kualitas, dan jam mulai tidur siang. Data hasil terapi didapatkan dari pencatatan hasil pemeriksaan fisik di rekam medik.

Hasil : Rerata usia dari 43 sampel adalah 50 tahun dengan jenis karsinoma sel skuamosa tidak berkeratin diferensiasi sedang. Pada analisis regresi logistik univariat, didapatkan adanya hubungan antara jam mulai tidur malam dengan respon klinis (p=0.032), dengan pengaruh yang cukup kuat (OR: 3,13, 95%CI; 1,10-8,88). Pada analisis multivariat, variabel jam mulai tidur malam masih memberikan signifikansi 0,032, dengan pengaruh terhadap respon yang cukup kuat (OR: 3,14,95%CI; 1,10-8,94), dimana jam mulai tidur yang lebih malam akan meningkatkan kemungkinan terjadinya respon tidakkomplit pada pasien.

Kesimpulan: Tidak terdapat hubungan antara kualitas tidur dan respon klinis pada pasien kanker serviks stadium lokal lanjut yang menjalani radioterapi. Terdapat hubungan antara jam mulai tidur dan respon klinis pada pasien kanker serviks stadium lokal lanjut yang menjalani radioterapi. Semakin telat pasien tidur akan meningkatkan kemungkinan respon klinis yang lebih buruk. Setelah disesuaikan dengan faktor-faktor lain, dapat diketahui bahwa jam mulai tidur pasien mempengaruhi secara independen terhadap respon klinis pada pasien kanker serviks stadium lokal lanjut yang menjalani radioterapi

---

Background: Cervical cancer is the second most common cancer and the third largest cause of mortality due to cancer in Indonesia. Definitive chemoradiotherapy is the main modality in treating locally advanced cervical cancer patient. Previous studies have shown that there is a difference in tumour response between patients who received radiation in the morning compared to the afternoon. It is known that the quality and quantity of sleep is associated with an increase in carcinogenic factors, and may cause immunosuppression. Research also shows that sleep disturbance is an independent prognostic factor in influencing overall survival. The aim of this study is to determine the relationship between sleep quality and quantity on clinical response in locally advanced cervical cancer patients undergoing radiotherapy.

Methods: This is a cross-sectional study in cervical cancer patients treated with definitive chemoradiotherapy in Radiotherapy Department, Ciptomangunkusumo Hospital. Quality and quantity of sleep data was extracted from previous interview done with study subjects by Ramli et al, which include the duration, quality, and night bedtime schedule, and also the frequency, duration, quality, and nap time. Clinical response was assessed by physical examination by the end of radiotherapy treatment.

Results: Mean age of 43 patients were 50 years with non-keratinizing, moderate differentiation squamous cell carcinoma. From univariate logistic regression, there was an association between bedtime schedule and clinical response (p=0.032) with a good strength (OR: 3.13; 95% CI: 1.1-8.88). Multivariate analysis also showed that with a late bedtime schedule, there was a higher chance of incomplete clinical response in patients (p=0.035, OR: 3.14; 95% CI: 1.1-8.94)

Conclusion: There was no relationship between quality of sleep and clinical response for locally advanced cervical cancer who underwent radiotherapy. Meanwhile, bedtime yield a significant association with cervical cancer clinical response. After further adjustment with other factors, bedtime was an independent factor for locally advanced cervical cancer clinical response. "

"Studi retrospektif ini bertujuan untuk mengetahui perbandingan respon terapi radiasi antara teknik konvensional 2D dengan pengecilan lapangan radiasi teknik 2D, 3DCRT atau brakiterapi pada pasien kanker nasofaring stadium dini (stadium I – IIa). Dari 20 sampel didapatkan respon komplit pada 17 pasien (85%) dan respon parsial pada 3 pasien (15%) (p=0.219). Efek samping akut yaitu dermatitis radiasi grade 3-4 adalah 5% (p=0.435), mukositis grade 3-4 adalah 15% (p=0.510) dan xerostomia grade 3-4 adalah 0% (p=0.517). Secara statistik tidak didapatkan perbedaan bermakna tetapi secara klinis mempunyai kesan ada kecenderungan bahwa dengan pengecilan lapangan radiasi teknik brakiterapi dan 3DCRT lebih baik dalam hal efek samping akut mukositis dibanding teknik 2D.

---

This retrospective study aimed to compare the response of radiation therapy between 2D conventional technique with the booster of 2D, 3DCRT or brachytherapy techniques in patients with early-stage nasopharyngeal cancer (stage I - IIa). From 20 sample, obtained complete response in 17 patients (85%) and partial response in 3 patients (15%) (p = 0.219). Side effects of acute radiation dermatitis grade 3-4 is 5% (p=0.435) , mucositis grade 3-4 is 15% (p=0.510) and xerostomia grade 3-4 is 0% (p=0.517). The result showed no satistically significant but clinically there is a tendency that with the booster of brachytherapy and 3DCRT techniques, are better compared with 2D technique in terms of acute mucositis side effects."

"Latar belakang: Salah satu modalitas terapi yang digunakan untuk meningkatkan angka kesintasan hidup pasien kanker payudara adalah dengan pemberian kemoterapi neoadjuvan. Pada umumnya kemoterapi neoajuvan kanker payudara stadium lanjut lokal di RSCM menggunakan regimen doxorubicin based. Namun belum ada penelitian lebih lanjut mengenai perbandingan kesintasan hidup lima tahun pasien kanker payudara lanjut lokal yang mendapatkan kemoterapi neoadjuvan doxorubicin based dengan non-doxorubicin based di RSCM. Tujuan: Mengetahui angka kesintasan hidup lima tahun penderita kanker payudara stadium lanjut lokal yang diberikan kemoterapi neoadjuvan doxorubicin based dan non-doxorubicin based di RSCM tahun 2011 ndash; 2016. Metode: Sebanyak 236 pasien kanker payudara stadium lanjut lokal yang mendapatkan kemoterapi neoadjuvan di RSCM tahun 2011-2016 menjadi sampel dalam penelitian ini. Analisis data dilakukan dengan metode Kapplan Meier, uji Log Rank dan Cox Regreession. Hasil penelitian: Angka kesintasan hidup lima tahun pasien kanker payudara stadium lanjut lokal yang diberi kemoterapi neoadjuvan doxorubicin based sebesar 37 dan non-doxorubicin based sebesar 48,9 . Pasien kanker payudara stadium lanjut lokal yang mendapatkan kemoterapi neoadjuvan doxorubicin based memiliki probabilitas 1,38 kali lebih cepat terjadinya kematian 95 CI 0,946 ndash; 2,026 setelah dikontrol dengan variabel invasi pembuluh limfatik, respon klinis, stadium, radiasi, jenis histopatologi, grade, dan status menopause. Invasi pembuluh limfatik merupakan variabel dengan hazard ratio terbesar yaitu 4,74 95 CI 3,213 ndash; 7,284. Kesimpulan: Kemoterapi neoadjuvan non-doxorubicin based menunjukkan kesintasan hidup yang lebih tinggi dibandingkan kemoterapi neoadjuvan doxorubicin based.

---

Background: One of the therapeutic modalities used to increase survival rates of breast cancer patients with neoadjuvan chemotherapy. In general, neoajuvan chemotherapy for locally advanced breast cancer at RSCM used a doxorubicin based regimen. But there has been no further study on the survival comparison of five years of locally advanced breast cancer patients who are neoadjuvan chemotherapy doxorubicin based or non doxorubicin based at RSCM.

Objectives: This study is conducted for determine 5 years survival rate of locally advanced breast cancer who were given neoadjuvan chemotherapy doxorubicin based and non doxorubicin based at RSCM in 2011 2016.

Methods: A total of 236 patients with locally advanced stage breast cancer who received neoadjuvan chemotherapy at RSCM in 2011 2016 were sampled in the study. Data analysis was perfomed by Kapplan Meier method, Log Rank and Cox Regreession analysis.

Results: 5 years survival rate of locally advanced breast cancer patients given neoadjuvan doxorubicin based chemotherapy is 37 and non doxorubicin based is 48.9. Locally advanced breast cancer patients receiving neoadjuvan doxorubicin based chemotherapy had a 1.38 times faster probability of death 95 CI 0.946 2.026 after controlled by invasive variation of lymphatic vein, clinical response, stage, radiation, histopathology, grade, And menopausal status. Invasion of lymphatic vessels is the variable with the largest hazard ratio of 4.74 95 CI 3,213 7,284.

Conclusions Neoadjuvan chemotherapy non doxorubicin based showed a higher survival than doxorubicin based for locally advanced breast cancer."

"Latar Belakang: Insiden kanker serviks di RSCM masih tinggi, sebagian besar datang pada stadium lanjut, dan angka harapan hidup yang masih rendah. Jika respon radiasi komplit dan eradikasi tumor lokoregional dapat tercapai pada pasien kanker serviks, diperkirakan dapat meningkatkan kesintasan. Oleh karena itu, kami bermaksud mengadakan penelitian terhadap respon terapi radiasi dan karakteristik klinis serta patologi yang berhubungan pada pasien kanker serviks di RSCM. Metode: Penelitian kohort ini dilakukan dengan menggunakan data sekunder terhadap 123 pasien kanker serviks stadium IIA-IIIB yang menjalani radiasi kuratif definitif sesuai protokol standard bulan Januari 2014-Des 2015 di RSUPN CiptoMangunkusumo. Dilakukan pencatatan karakteristik klinis dan patologis sebelum radiasi, Dicatat juga efek samping akut gastrointestinal, traktus genitourinaria, dan hematologis selama menjalani protokol radiasi sampai 3 bulan pasca radiasi. Data respon tiga bulan pasca radiasi lengkap berdasarkan klinis dan pemeriksaan ultrasonografi transrektal/transvaginal dicatat dan diklasifikasikan sesuai Response Evaluation Criteria in Solid Tumors RECIST. Hasil: Dari 123 kasus, 84 kasus 68,29 diperoleh respon komplit, 30 kasus 24,39 respon parsial, 6 kasus 4,88 respon stabil, dan 3 kasus 2,44 respon progresif. Berdasarkan efek samping akut gastrointestinal, tidak didapatkan efek samping derajat 0 pada 99 kasus 80,49, derajat 1 pada 20 kasus 16,26, derajat 2 pada 4 kasus 3,25, derajat 3 pada 0 kasus 0. Berdasarkan efek samping akut genitourinaria, tidak didapatkan efek samping derajat 0 pada 105 kasus 85,37, derajat 1 pada 17 kasus 13,82, derajat 2 pada 1 kasus 0,81, dan derajat 3 pada 0 kasus 0. Berdasarkan efek samping akut hematologis, tidak didapatkan efek samping derajat 0 pada 108 kasus 87,80, derajat 1 pada 15 kasus 12,20, derajat 2 pada 0 kasus 0, dan derajat 3 pada 0 kasus 0. Dengan membandingkan kelompok respon komplit dan tidak respon parsial, stabil, progresif didapatkan faktor usia dengan p=0,266 RR 0,87;IK95 0,67-1,12, klasifikasi tekanan darah dengan p=0,882 RR 0,98; IK95 0,76-1,27, Indeks Masa Tubuh dengan p= 0,397 RR 1,06;IK95 0,83-1,34, kadar hemoglobin dengan p= 0,193 RR 0,71;IK95 0,40-1,27, jumlah leukosit darah dengan p=0,969 RR=1,00; IK95 0,78-1,29, kadar albumin darah dengan p= 0,198 RR 0,73;IK95 0,44-1,20, stadium FIGO dengan p=0,526 RR 1,08; IK95 0,85-1,38, diameter tumor terbesar dengan p=0,034 RR 1,30; IK95 1,03-1,63, jenis histopatologis dengan p=0,159 RR 1,18;IK95 0,90-1,55, dan derajat diferensiasi dengan p=0,469. Pada analisa multivariat, didapatkan hubungan bermakna antara diameter tumor p=0,036;RR 2,64; IK95 1,07-6,56 dengan respon radiasi komplit. Kesimpulan: Gambaran respon radiasi kuratif definitif pada kanker serviks stadium IIA-IIIB di RSCM adalah 68,29 respon komplit, 24,39 respon parsial, 4,88 respon stabil, dan 2,44 progresif. Efek samping akut gastrointestinal, genitourinaria, dan hematologis pada umumnya tidak terjadi selama dan sampai 3 bulan pasca radiasi, yaitu 80,49 tidak mengalami efek samping akut gastrointestinal, 85,37 tidak mengalami efek samping akut genitourinaria, dan 87,80 tidak terjadi efek samping akut hematologi. Sebagian besar efek samping akut yang terjadi berderajat rendah yaitu grade 1 dan 2 traktus gastrointestinal, masing-masing 16,26 dan 3,25, grade 1 dan 2 traktus genitourinaria, yaitu masing-masing 13,82 dan 0,81, dan grade 1 hematologi, yaitu 12,20. Terdapat hubungan bermakna antara diameter tumor terbesar dengan respon komplit radiasi. Tidak terdapat hubungan bermakna antara usia, Indeks Masa Tubuh, kadar hemoglobin, jumlah leukosit darah, kadar albumin serum, stadium FIGO, jenis histopatologis, dan derajat diferensiasi dengan respon terapi radiasi.

---

Background: The incidence of cervical cancer was still high in RSCM, whom most of them was found in advanced stage. The issue that still become a problem related to radiotherapy on those patients was non satisfying local tumor control, which range 20 50. If we can reach complete response and eradication of locoregional tumor on cervical cancer patients, it is estimated that the survival rate will increase. Therefore, we conducted a research to find out response of radiotherapy and related clinic pathologic characterictics on cervical cancer patients in our hospital.

Methods: This cohort study used secondary data on 123 patients of cervical cancer stage IIA IIIB who had undergone radiation therapy based on standard protocol in our hospital, during Januari 2014 to Dec 2015. The clinical factors of those patients, such as age, Body Mass Index, blood pressure, hemoglobin level, blood leucocyte count, serum albumin, largest tumor diameter FIGO staging and pathologic characteristic, i.e histopathology and grading were recorded. During radiation protocol until 3 months post radiation, we also noted any side effects of gastrointestinal tract, genitourinary tract, and hematologic. Evaluation of radiotherapy response was based on Response Evaluation Criteria in Solid Tumors RECIST.

Results: Among 123 cases, 84 cases or 68.29 was complete response, 30 cases or 24.39 was partial response, 6 cases or 4.88 was stabile response, and 3 cases or 2.44 was progressive. Based on gastrointestinal side effect, there was no side effect or grade 0 on 99 cases 80.49, grade 1 on 20 cases 16.26, grade 2 on 4 cases 3.25, grade 3 on 0 case 0. Based on side effect of genitourinary, there was no side effect or grade 0 on 105 cases 85,37, grade 1 on 17 cases 13.82, grade 2 on 1 case 0.81, grade 3 on 0 case 0. Based on hematologic side effects, there was no side effect on 108 cases 87.80, grade 1 on 15 cases 12.20, grade 2 on 0 case 0, grade 3 on 0 case 0. On bivariate analysis, p of each factors were age p 0.266 RR 0.87 0.67 1.12, Body Mass Index p 0.397, blood pressure classification p 0.658 RR 0.98 0.76 1.27, largest tumor diameter p 0.034 RR 1.30 1.03 1.63, haemoglobin level p 0.193 RR 0.98 0.76 1.27, blood leucocyte count p 0.969 RR 1.00 0.78 1.29, FIGO staging II vs III p 0.526 RR 1.08 0.85 1.38, histopathology result squamous cell carcinoma vs nonsquamous cell carcinoma p 0.159 RR 1.18 0.90 1.55, and grading p 0.469. on multivariate analysis, tumor diameter was statistically significant, with p 0.036 RR 2.64 1.07 6.56.

Conclusion: Most of definitive curative radiotherapy response on cervical cancer stage IIA IIIB was complete 68.29. Partial response was 24.49, stable response was 4.88, and progressive was 2.44. The Acute side effect of gastrointestinal tract, genitourinary tract, and hematologic were commonly can be tolerable during and 3 months post radiation therapy. Clinico pathologic characteristic that significantly related to complete response of radiotherapy were largest tumor diameter."

"Latar Belakang: Kanker serviks merupakan keganasan yang sering ditemukan diberbagai negara pada wanita setelah kanker payudara. Kanker serviks berhubungan dengan angka kematian yang tinggi. FIGO merekomendasikan penggunaan MRI sebagai alat diagnosis dan prognosis. Tingkat proliferasi tumor berhubungan dengan respon terapi yang dapat diketahui dengan nilai signal intensitas sekuens T2WI. Saat ini belum ada penelitian yang menilai perbedaan nilai SI sekuens T2WI dengan respon terapi radiasi pada kanker serviks tipe karsinoma sel skuamosa. Tujuan: Memperoleh perbedaan nilai rasio sekuens T2WI pada pasien kanker serviks karsinoma sel skuamosa yang mengalami respon dan tidak respon terapi. Metode: Sebanyak 39 subjek penelitian dilakukan pemeriksaan MRI pelvis sebelum dan setelah terapi radiasi. Data penelitian diambil menggunakan sekuens T2WI dan data histologi berasal dari EHR RSUPN Dr. Cipto Mangunkusumo. Dilakukan analisis data menggunakan uji normalitas Saphiro-Wilk dan uji T berpasangan. Hasil: Pada kelompok umur, status pernikahan, status obstetri dan klasifikasi FIGO, didapatkan hasil tidak signifikan (p = 0,19, p = 0,348, p = 0,153, dan p = 0,995; p > 0,05). Begitupun pada kelompok respon dan tidak respon dengan RECIST 1.1, didapat hasil signifkan dengan p = 0,000; p < 0,05) sedangkan pada kelompok perbedaan nilai rasio sekuens T2WI, didapatkan hasil yang tidak signifikan (p = 0,436, p > 0,05). Kesimpulan: Tidak terdapat perbedaan nilai rasio sekuens T2WI pada kelompok respon dan tidak respon terapi berdasarkan kriteria RECIST 1.1 pada kanker serviks tipe karsinoma sel skuamosa.

---

Background: Cervical cancer is a malignancy that is often found in various countries in women after breast cancer. Cervical cancer is associated with a high mortality rate. FIGO recommends the use of MRI as a diagnostic and prognostic tool. The rate of tumor proliferation is related to the therapeutic response which can be determined by the value of the T2WI sequence intensity signal. Currently, there are no studies that assess the differences in SI values of T2WI sequences and the response to radiation therapy in squamous cell carcinoma type cervical cancer.

Objective: Obtain differences in the value of the T2WI sequence ratio in patients with cervical cancer squamous cell carcinoma who experienced and did not respond to therapy.

Methods: A total of 39 study subjects were subjected to pelvic MRI examinations before and after radiation therapy. The research data were taken using T2WI sequences and histological data came from EHR RSUPN Dr. Cipto Mangunkusumo. Data were analyzed using the Saphiro-Wilk normality test and paired T test.

Results: In the age group, marital status, obstetric status and FIGO classification, the results were not significant (p = 0.19, p = 0.348, p = 0.153, and p = 0.995; p> 0.05). Likewise in the response dan unresponse group with RECIST 1.1, the results were significant with p = 0.000; p <0.05), while the difference in the value of the T2WI sequence ratio, the results were not significant (p = 0.436, p> 0.05).

Conclusion: There is no difference in the value of the T2WI sequence ratio in the response group and no response to therapy based on RECIST 1.1 criteria in squamous cell carcinoma type cervical cancer."

"[Tujuan: Untuk mengetahui profil pasien kanker rektum di Departemen Radioterapi RSCM. Metode: Dilakukan penelitian restrospektif deskriptif analitik terhadap 144 pasien kankerrektum yang menjalani radiasi di Departemen Radioterapi RSCM periode Januari 2009Januari2014, dilihat karakteristik pasien dan tumor. Respons radiasi dinilai menggunakanmetode RECIST 1.1. Hubungan antara OTT dan DTT dengan respons radiasi dinilai dengankorelasi Spearman dan analisis kesintasan dihitung dengan kurva Kaplan Meier. Hasil: Pasien laki-laki sebesar 65.9%, median usia 53 (23-81) tahun dengan mayoritas beradapada kelompok usia 50-59 tahun. Tipe histopatologi terbanyak adalah adenokarsinoma(88.8%) dan pasien paling banyak datang dengan stadium IIIB (25.0%). Kemoradiasidilakukan pada 29.8% pasien, dengan toksisitas radiasi akut terbanyak adalah pada kulit(derajat I) sebesar 20.1%. Respons radiasi yang dinilai dengan metode RECIST 1.1menunjukkan respons terbanyak adalah stabil (71.4%). Tidak ditemukan korelasi antara OTTdan DTT dengan respons radiasi. Dari 118 pasien, didapatkan analisis kesintasan keseluruhan3 dan 5 tahun masing-masing adalah 65% dan 45% dengan median survival 59 bulan. Padakelompok pasien yang menjalani radiasi panjang, analisis kesintasan keseluruhan 3 dan 5tahun masing-masing adalah masing-masing 91% dan 78%. Kesimpulan: Karakteristik pasien rektum di Departemen Radioterapi RSCM yang berbedadengan berbagai studi sebelumnya hanya usia. Respons radiasi yang paling banyak dijumpai adalah stabil. Tidak ditemukan korelasi antara OTT dan DTT dengan respons radiasi.;Purpose: To obtain the profile of rectal cancer patients in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo.Method: A restrospective study was conducted over 144 rectal cancer patients undergone radiation therapy in Department of Radiotherapy, National General Hospital of CiptoMangunkusumo during period of January 2009 to January 2014. The characteristics ofpatients and tumour were assessed. The radiation response was evaluated with the RECIST1.1 method. The correlation between OTT and DTT with radiation response was analyzedwith Spearman?s correlation and the survival analysis was determined using Kaplan-Meiercurve. Result: The majority of patients were male (65.9%), with median age of 53 (23-81) years oldwhere most patients belonged to age group of 50-59 years old. The most frequenthistopathologic type found was adenocarcinoma (88.8%) with most patients were in stageIIIB (25.0%). Chemoradiation was performed in 29.8% of patients, and grade I skin toxicitywas the most frequent acute side effect of radiation found (20.1%). Radiation responseassessed with the RECIST 1.1 method showed stable disease as the mostly seen response(71.4%). There was no correlation found between OTT and DTT with radiation response.Overall survival from 118 patients for 3 and 5 years were 65% and 45%, respectively, withmedian survival of 59 months. In the group of patients underwent long-course radiotherapy,the overall survival for 3 and 5 years were 91% and 78%, respectively. Conclusion: The sole characteristic of rectal cancer patients in Department of Radiotherapy atCipto Mangunkusumo Hospital that is different from previous studies is the age group wheremost patients were in. Stable disease is the most frequent radiation response. There was no correlation found between OTT and DTT with radiation response., Purpose: To obtain the profile of rectal cancer patients in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo.Method: A restrospective study was conducted over 144 rectal cancer patients undergone radiation therapy in Department of Radiotherapy, National General Hospital of CiptoMangunkusumo during period of January 2009 to January 2014. The characteristics ofpatients and tumour were assessed. The radiation response was evaluated with the RECIST1.1 method. The correlation between OTT and DTT with radiation response was analyzedwith Spearman’s correlation and the survival analysis was determined using Kaplan-Meiercurve. Result: The majority of patients were male (65.9%), with median age of 53 (23-81) years oldwhere most patients belonged to age group of 50-59 years old. The most frequenthistopathologic type found was adenocarcinoma (88.8%) with most patients were in stageIIIB (25.0%). Chemoradiation was performed in 29.8% of patients, and grade I skin toxicitywas the most frequent acute side effect of radiation found (20.1%). Radiation responseassessed with the RECIST 1.1 method showed stable disease as the mostly seen response(71.4%). There was no correlation found between OTT and DTT with radiation response.Overall survival from 118 patients for 3 and 5 years were 65% and 45%, respectively, withmedian survival of 59 months. In the group of patients underwent long-course radiotherapy,the overall survival for 3 and 5 years were 91% and 78%, respectively. Conclusion: The sole characteristic of rectal cancer patients in Department of Radiotherapy atCipto Mangunkusumo Hospital that is different from previous studies is the age group wheremost patients were in. Stable disease is the most frequent radiation response. There was no correlation found between OTT and DTT with radiation response.]"

"ABSTRAKObjektif: Pembedahan merupakan tatalaksana paliatif utama dari kanker periampular stadium lanjut, namun hal tersebut memiliki angka komplikasi postoperatif, rekurensi penyakit, dan mortalitas yang tinggi. Objektif dari penelitian ini yaitu untuk mengetahui faktor prognostik dan sintasan penyakit selama 1 tahun dari kanker periampular stadium lanjut pada Rumah Sakit Cipto Mangunkusumo. Metode: Penelitian ini merupakan uji analisis sintas dengan desain kohort retrospektif. Data dikumpulkan dari pendaftaran per bulan dari Divisi Bedah Digestif dan rekam medis dari Rumah Sakit Cipto Mangunkusumo dari Januari 2015 hingga Desember 2017. Sintasan penyakit satu tahun dianalisis dengan metode Kaplan-Meier. Dilakukan analisis bivariat dan multivariat dari masing-masing variabel pada sintasan satu tahun pasien. Hasil: Sintasan penyakit selama 1 tahun dari pasien post-double bypass yaitu 19% dengan median (minimal-maksimal) sintasan yaitu 159 (2-365) hari. Berdasarkan perbandingan antarkelompok sintasan pasien, hemoglobin (p=0,013) dan klasifikasi ASA (p=0,001) memiliki estimasi sintasan yang bermakna secara statistik. Pada analisis multivariat, jenis kelamin (p=0,250, HR=3,910) dan nilai laboratorium preoperatif (albumin (p=0,350, HR=0,400), aspartat aminotransferase (AST) (p=0,13, HR=5,110) dan alanin aminotransferase (ALT) (p=0,280, HR=0,05)) berhubungan dengan sintasan. Kesimpulan: Sintasan selama 1 tahun pada pasien post-double bypass pada Rumah Sakit Cipto Mangunkusumo rendah. Laju mortalitas satu bulan yang rendah mengindikasikan bahwa double bypass merupakan prosedur yang aman. Faktor prognostik yang berhubungan dengan sintasan yang rendah yaitu jenis kelamin perempuan dan nilai laboratorium preoperatif (albumin, AST, ALT).

---

ABSTRACTObjective: Surgery is the main palliative treatment of advanced periampullary cancer, however it has high number of post-operative complication, disease recurrence and mortality. The objective of the current study was to examine prognostic factors and one year survival rate of advanced stage periampullary cancer in Cipto Mangunkusumo Hospital. Methods: This is a survival analysis test study with retrospective cohort design. Data were collected from monthly registration of Digestive Surgery Division and medical records from Cipto Mangunkusumo Hospital from January 2015 until December 2017. One year survival rate were analyzed with Kaplan-Meier method. Bivariate and multivariate analysis of each variable on one year survival of the patient were done. Result: One year survival rate of the post-double bypass patients is 19% with median (min-max) survival 159 (2-365) days. From the comparison of survival rate based patients grouping, hemoglobin (p=0.013) and ASA classification (p=0.001) have significant survival estimation statistically. In multivariate analysis, gender (p=0.250, HR=3.910) and preoperative laboratory values (albumin (p=0.350, HR=0.400), aspartate aminotransferase (AST) (p=0.13, HR=5.110) and alanine aminotransferase (ALT) (p=0.280, HR=0.05)) are associated with survival rate. Conclusion: One year survival rate of post double bypass patients in Cipto Mangunkusumo hospital is low. Low one month mortality rate indicates double bypass is a safe procedure. Prognostic factors that associated with lower survival are woman gender and preoperative laboratory value (albumin, AST, ALT)."

"Pendahuluan: Kanker payudara merupakan salah satu penyebab kematian dan morbiditas utama pada perempuan. Kanker ini paling sering ditemukan pada perempuan di seluruh dunia. Di Amerika Serikat (AS), merupakan penyebab kedua tersering kematian pada perempuan. Penyebab besarnya angka morbiditas dan mortalitas antara lain disebabkan oleh tendensi kanker payudara primer untuk bermetastasis ke lokasi regional dan metastasis jauh serta tidak adanya terapi klinis yang efektif untuk metastasis. Pemahaman yang lebih baik mengenai metastasis pada kanker payudara diperlukan untuk memperbaiki tatalaksana klinis serta membuka potensi adanya strategi prognostik serta terapeutik baru pada metastasis kanker payudara. Metode: Jenis penelitian ini adalah deskriptif retrospektif. Dilakukan di Rumah Sakit Cipto Mangunkusumo (RSCM) dengan mengumpulkan data rekam medis pada pasien-pasien keganasan payudara di poliklinik onkologi RSCM periode Januari 2008 hingga Desember 2011. Hasil: Didapatkan 112 kasus kanker payudara dari total 126 kasus yang mengalami metastasis sehingga angka metastasis di RSCM sepanjang tahun 2008-2011 sebesar 8,55%. Kasus terbanyak dengan metastasis adalah tipe karsinoma payudara tipe duktal invasif (n = 94) dengan metastasis terbanyak ke tulang (n = 69), diikuti oleh metastasis ke paru (n = 22), 4 metastasis ke hepar, tulang, dan paru; 5 metastasis paru dan tulang; 4 metastasis hepar dan paru, 4 metastasis hepar dan tulang; 3 metastasis hepar; dan 1 metastasis paru dan otak. 46 pasien (41.07%) merupakan kasus primer 66 pasien (58.93%) merupakan kasus residif. Tiga puluh sembilan kasus datang dengan stadium 2 atau 3, 73 pasien datang dalam stadium 4. Kesimpulan: Tatalaksana keganasan payudara merupakan tantangan bagi seluruh ahli bedah umum dan onkologi dan membutuhkan penatalaksanaan holistik. Dibutuhkan kerjasama dari berbagai pemangku kepentingan agar pasien berobat secara teratur dan mendapatkan kualitas hidup yang baik.

---

Background: Breast cancer is one of the leading causes f morbidity and mortality in women. This cancer found in every corner of the world. In the United States, breast cancer is the second cause of death in women. The cause of this huge number of morbidity and mortality is due to the tendency of primary breast cancer to metastasize to regional dan distant sites. Moreover there are no effective treatments for metastatic disease. Better understanding on metastasis of breast cancer is needed to improve clinical treatment and open up potency on prognostic and therapeutic strategy for metastatic disease.

Method: This was a retrospective descriptive study performed in Cipto Mangunkusumo Hospital (RSCM) by collecting data from medical record of breast cancer patients in out patient clinic in RSCM from January 2008 to December 2011.

Result: There are 112 cases of breast cancer from total 126 cases with metastasis. The incidence of metastasis in breast cancer in RSCM from 2008 to 2011 is 8.55%. Ductal invasive is the most common type of breast cancer to have metastasis (n = 94). The most common site for metastasis is the bone (n = 69), followed by lung (n = 22), liver (n = 4), lung and liver (n = 1), lung and bone (n = 5), liver and lung (n = 4), liver and bone (n = 4), lung and brain (n = 1). 46 patients (41.07%) were primary cases and 66 (58.93%) were residif cases. 39 cases were in stadium 2 or 3, and 73 patient came in stadium 4.

Conclusion: Treatment of breast cancer is a challenge for every surgeons. It needs holistic and comprehensive treatment. Cooperation from the stakeholders is needed to make sure that these patients have a good compliance in the treatment and have good quality of life. "

"Tesis ini bertujuan Untuk mengetahui pengaruh merokok pada kesintasan penderita kanker serviks stadium lanjut di Rumah Sakit Umum Ciptomangunkusumo. Penelitian ini bersifat kohort retrospektif. Hasil penelitian didapatkan tingkat merokok oleh pasien dan atau suami pasien tidak signifikan secara statistik sebagai faktor prognosis terhadap pasien kanker serviks stadium lanjut di RSCM. Kesintasan 5 tahun pasien kanker serviks stadium lanjut dalam studi kami adalah 22 bulan (4-58 bulan) dengan persentase kesintasan 22,6%. Dengan analisis multivariat didapatkan bahwa hanya ukuran tumor dan stadium kanker bermakna secara statistik terhadap kesintasan.

---

This thesis aims to determine the effect of smoking on the survival rate of advanced stage cervical cancer patients in the Ciptomangunkusumo General Hospital. This study is a retrospective cohort. The results showed that smoking levels by the patient or the patient's husband was not statistically significant as a prognostic factor for patients with advanced cervical cancer in RSCM. 5-year survival of patients with advanced cervical cancer in our study was 22 months (4-58 months) with a percentage of 22.6% survival rate. By multivariate analysis. it was only tumor size and stage of the cancer that statistically significant to the survival rate."